IC-8 Apthera IOL New Enrollment Post Approval Study

← catalyst calendar

NCT06060041 · readout in 407 d

Sponsored by Bausch & Lomb Incorporated (industry) · BLCO — their whole pipeline →.

Phase

—

Status

Recruiting

Study type

Observational

Enrollment

435estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2023-09-08

actual

When the study began enrolling

Primary completion

2027-09-30

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2027-09-30

estimated

The whole study's end, after follow-up

First posted

2023-09-29

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-01-12

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Cataract
Presbyopia
Posterior Capsule Opacification

Primary outcomes

what the primary-completion date above is the date OF

Rate of any additional Nd:YAG laser treatments beyond the initial Nd:YAG laser treatment

measured 24 Months post IC-8 Apthera IOL Implantation

Nd:YAG laser treatment outcome and/or complications

measured 24 Months post IC-8 Apthera IOL Implantation

IOL related assessments